Zjamp Group Co Ltd is mainly engaged in the business which covers comprehensive agricultural services, automotive trading services, and pharmaceutical production and sales. It is a leader in the commercial circulation industry under the new development pattern of dual circulation and an enterprise in the urban and rural commercial service industry of the national supply and marketing cooperative system.
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Zjamp Group has a last 12-month revenue of n/a and a last 12-month EBITDA of n/a.
In the most recent fiscal year, Zjamp Group achieved revenue of $5.6B and an EBITDA of $196M.
Zjamp Group expects next 12-month revenue of XXX   and NTM EBITDA of XXX
See Zjamp Group valuation multiples based on analyst estimatesFY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
---|---|---|---|---|---|
Revenue | $5.6B | n/a | XXX | XXX | XXX |
Gross Profit | $448M | $452M | XXX | XXX | XXX |
Gross Margin | 8% | NaN% | XXX | XXX | XXX |
EBITDA | $196M | n/a | XXX | XXX | XXX |
EBITDA Margin | 3% | NaN% | XXX | XXX | XXX |
Net Profit | $90.7M | $84.0M | XXX | XXX | XXX |
Net Margin | 2% | NaN% | XXX | XXX | XXX |
Net Debt | n/a | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, Zjamp Group's stock price is CNY 9 (or $1).
Zjamp Group has current market cap of CNY 4.7B (or $644M), and EV of CNY 2.3B (or $322M).
See Zjamp Group trading valuation dataEV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
---|---|---|---|---|---|---|
$322M | $644M | XXX | XXX | XXX | XXX | n/a |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, Zjamp Group has market cap of $644M and EV of $322M.
Zjamp Group's trades at n/a LTM EV/Revenue multiple, and n/a LTM EBITDA.
Analysts estimate Zjamp Group's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Zjamp Group and 10K+ public compsFY 2024 | FY 2025E | FY 2026E | FY 2027E | |
---|---|---|---|---|
EV | $322M | XXX | XXX | XXX |
EV/Revenue | n/a | XXX | XXX | XXX |
EV/EBITDA | n/a | XXX | XXX | XXX |
P/E | n/a | XXX | XXX | XXX |
P/E/Growth | n/a | XXX | XXX | XXX |
EV/FCF | n/a | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpZjamp Group's NTM/LTM revenue growth is n/a
Zjamp Group's revenue per employee for the last fiscal year averaged n/a, while opex per employee averaged n/a for the same period.
Over next 12 months, Zjamp Group's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Zjamp Group's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Zjamp Group and other 10K+ public compsFY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
---|---|---|---|---|---|
Revenue Growth | n/a | XXX | XXX | XXX | XXX |
EBITDA Margin | n/a | XXX | XXX | XXX | XXX |
EBITDA Growth | n/a | XXX | XXX | XXX | XXX |
Rule of 40 (SaaS-only) | n/a | XXX | XXX | XXX | XXX |
Revenue per Employee | n/a | XXX | XXX | XXX | XXX |
Opex per Employee | n/a | XXX | XXX | XXX | XXX |
S&M Expenses to Revenue | 1% | XXX | XXX | XXX | XXX |
G&A Expenses to Revenue | 0% | XXX | XXX | XXX | XXX |
R&D Expenses to Revenue | 0% | XXX | XXX | XXX | XXX |
Opex to Revenue | 3% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
EV/Revenue | EV/EBITDA | |||||
---|---|---|---|---|---|---|
2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
MedPlus India | XXX | XXX | XXX | XXX | XXX | XXX |
Pague Menos | XXX | XXX | XXX | XXX | XXX | XXX |
Droga Raia | XXX | XXX | XXX | XXX | XXX | XXX |
Redcare Pharmacy | XXX | XXX | XXX | XXX | XXX | XXX |
Oriola | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Zjamp Group acquired XXX companies to date.
Last acquisition by Zjamp Group was XXXXXXXX, XXXXX XXXXX XXXXXX . Zjamp Group acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiplesAcquired Company | EV | EV/Revenue | EV/EBITDA |
---|---|---|---|
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign UpWhen was Zjamp Group founded? | Zjamp Group was founded in 1999. |
Where is Zjamp Group headquartered? | Zjamp Group is headquartered in China. |
Is Zjamp Group publicy listed? | Yes, Zjamp Group is a public company listed on SHE. |
What is the stock symbol of Zjamp Group? | Zjamp Group trades under 002758 ticker. |
When did Zjamp Group go public? | Zjamp Group went public in 2015. |
Who are competitors of Zjamp Group? | Similar companies to Zjamp Group include e.g. MedPlus India, Pague Menos, Droga Raia, Redcare Pharmacy. |
What is the current market cap of Zjamp Group? | Zjamp Group's current market cap is $644M |
Is Zjamp Group profitable? | Yes, Zjamp Group is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.